60 related articles for article (PubMed ID: 21166663)
1. Abnormality of RUNX1 signal transduction in psoriatic CD34+ bone marrow cells.
Yin G; Li J; Wan Y; Hou R; Li X; Zhang J; Cheng T; Zhang K
Br J Dermatol; 2011 May; 164(5):1043-51. PubMed ID: 21166663
[TBL] [Abstract][Full Text] [Related]
2. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis.
Helms C; Cao L; Krueger JG; Wijsman EM; Chamian F; Gordon D; Heffernan M; Daw JA; Robarge J; Ott J; Kwok PY; Menter A; Bowcock AM
Nat Genet; 2003 Dec; 35(4):349-56. PubMed ID: 14608357
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization of T cells differentiated in vitro from bone marrow-derived CD34 cells of psoriatic patients with family history.
Zhang K; Li X; Yin G; Liu Y; Tang X
Exp Dermatol; 2010 Aug; 19(8):e128-35. PubMed ID: 20002175
[TBL] [Abstract][Full Text] [Related]
4. Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
J Pathol; 2003 Jan; 199(1):107-14. PubMed ID: 12474233
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation status of p15 and p21 genes in HPP-CFCs of bone marrow of patients with psoriasis.
Zhang K; Zhang R; Li X; Yin G; Niu X
Eur J Dermatol; 2009; 19(2):141-6. PubMed ID: 19153068
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of CD4+CD25+ regulatory T cells differentiated in vitro from bone marrow-derived haematopoietic cells of psoriasis patients with a family history of the disorder.
Zhang K; Li X; Yin G; Liu Y; Niu X; Hou R
Br J Dermatol; 2008 Feb; 158(2):298-305. PubMed ID: 18070209
[TBL] [Abstract][Full Text] [Related]
7. T cell signaling abnormalities in systemic lupus erythematosus are associated with increased mutations/polymorphisms and splice variants of T cell receptor zeta chain messenger RNA.
Nambiar MP; Enyedy EJ; Warke VG; Krishnan S; Dennis G; Wong HK; Kammer GM; Tsokos GC
Arthritis Rheum; 2001 Jun; 44(6):1336-50. PubMed ID: 11407693
[TBL] [Abstract][Full Text] [Related]
8. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
9. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
10. The mRNA expression and promoter methylation status of the p16 gene in colony-forming cells with high proliferative potential in patients with psoriasis.
Zhang K; Zhang R; Li X; Yin G; Niu X; Hou R
Clin Exp Dermatol; 2007 Nov; 32(6):702-8. PubMed ID: 17509057
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of SLC22A4, SLC22A5, SLC9A3R1 and RUNX1 variants in psoriatic arthritis.
Butt C; Sun S; Greenwood C; Gladman D; Rahman P
Rheumatology (Oxford); 2005 Jun; 44(6):820-1. PubMed ID: 15769785
[No Abstract] [Full Text] [Related]
13. The T cell receptor repertoire in psoriatic synovitis is restricted and T lymphocytes expressing the same TCR are present in joint and skin lesions.
Borgato L; Puccetti A; Beri R; Codella O; Frigo A; Simeoni S; Pacor ML; Corrocher R; Lunardi C
J Rheumatol; 2002 Sep; 29(9):1914-9. PubMed ID: 12233886
[TBL] [Abstract][Full Text] [Related]
14. Activator protein 1 DNA binding activity is decreased in lesional psoriatic skin compared with nonlesional psoriatic skin.
Johansen C; Kragballe K; Rasmussen M; Dam TN; Iversen L
Br J Dermatol; 2004 Sep; 151(3):600-7. PubMed ID: 15377346
[TBL] [Abstract][Full Text] [Related]
15. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: evidence for TRAIL induction via the T cell receptor signaling pathway.
Musgrave BL; Phu T; Butler JJ; Makrigiannis AP; Hoskin DW
Exp Cell Res; 1999 Oct; 252(1):96-103. PubMed ID: 10502402
[TBL] [Abstract][Full Text] [Related]
16. Analysis of T cell receptor alpha-chain variable region (Valpha) usage and CDR3alpha of T cells infiltrated into lesions of psoriasis patients.
Hwang HY; Kim TG; Kim TY
Mol Immunol; 2006 Feb; 43(5):420-5. PubMed ID: 16337484
[TBL] [Abstract][Full Text] [Related]
17. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis.
Wang Y; Belflower RM; Dong YF; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2005 Sep; 20(9):1624-36. PubMed ID: 16059634
[TBL] [Abstract][Full Text] [Related]
18. Overexpression or knock-down of runt-related transcription factor 1 affects BCR-ABL-induced proliferation and migration in vitro and leukemogenesis in vivo in mice.
Yang LJ; Yu WD; DU JB; Chao S; Chen MX; Zhao HH; Guo JZ
Chin Med J (Engl); 2009 Feb; 122(3):331-7. PubMed ID: 19236814
[TBL] [Abstract][Full Text] [Related]
19. Evidence for distinct intracellular signaling pathways in CD34+ progenitor to dendritic cell differentiation from a human cell line model.
St Louis DC; Woodcock JB; Franzoso G; Blair PJ; Carlson LM; Murillo M; Wells MR; Williams AJ; Smoot DS; Kaushal S; Grimes JL; Harlan DM; Chute JP; June CH; Siebenlist U; Lee KP
J Immunol; 1999 Mar; 162(6):3237-48. PubMed ID: 10092775
[TBL] [Abstract][Full Text] [Related]
20. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
